Zyme Communications Ltd

What do you think 2025 holds for the biopharma industry? In this first instalment of 'Scrip Asks', Citeline's Eleanor Malone discusses 'The State of the Biopharma Industry'. The article outlines how, after two years of capital constraint, innovation remains the sector’s driving force, but due diligence is key. The piece features fascinating insights from industry leaders, including Jennifer Schneider (Centauri Therapeutics Limited), Billy Boyle (Owlstone Medical) and Christian Dillon (PhoreMost Ltd). Read more here: https://bit.ly/4hhREia

Thank you Kadans Science Partner, Canary Wharf Group, The Royal Veterinary College and One Nucleus for a great event yesterday - From Innovation to Adoption in Gene Therapies. The event brought together experts and innovators, with an inspiring programme of talks focused on accelerating the journey from transformative science to real-world adoption. Beautiful views and a lovely opportunity to catch up with Cristina Stanciu (Zenzero), Liz Barton (VET.CT), Dave Graham, Chris Howie, Kat Arney and Tony Jones!

Didn’t make it to #SLAS2025? Don’t worry, Zyme Communications Ltd were your eyes and ears, sharing their industry updates in this conference report https://hubs.ly/Q038zQ180

With #SLAS2025 taking place one month ago, you can now read our conference report which is now live on BioTechniques! Reflecting on this year's flagship event from SLAS (Society for Laboratory Automation and Screening), the report summarises key announcements, awards, spotlight talks, and the latest innovative technologies that were showcased on the exhibition floor in San Diego. Read it here: https://shorturl.at/Ueq9H

?? Just one month to go until #BioTrinity 2025! OBN (UK) Ltd's flagship life science conference returns to London on 1st - 2nd April, where they expect to welcome ~900 delegates including early and emerging life science R&D companies, investors, big pharma, academics, charities, government representatives and industry services providers. Attendees this year can expect: ?? Dedicated scientific dual track, featuring showcase presentations from companies across 14 different therapy areas ?? Business and investor track, covering fundraising, the stock market, M&As, leadership and more ?? Exhibition hall ?? Networking events and private partnering meetings ?? Academic poster presentation session For the full programme and to find out more, visit: https://bit.ly/3OG0dHn Already attending? Get in touch and schedule time to meet with our team ? [email protected]

Our CEO Billy Boyle has been quoted in Drug Discovery World's Industry predictions for 2025! https://lnkd.in/eUSmPiUd

Learning to suppress fear is something that we all do throughout our lives, but how does our brain do it? This is the question a team at University College London has sought to answer. Using mice and a growing shadow to simulate a swooping bird, the team identified critical pathways involved in the fear response. They noted that, when the mice learned not to fear the shadow, a pathway was activated in the brain which suppressed this instinctual fear response. Although only early-stage research, it is hoped that this discovery could help to develop novel treatment strategies for conditions such as anxiety and PTSD. Read more in Science Magazine: https://bit.ly/42IIGqm

Today Sphere Fluidics has announced its rebrand to Sphere Bio. The new brand change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions. Following significant operational scale-up and commercial growth over the past two years, the rebrand represents expanded market focus and growth potential in impactful and emerging research areas. #SingleCellAnalysis #Microfluidics #LifeSciences Read the full press release here:?https://bit.ly/3XdgPLi

Today Nuclera appointed Seth Benson as Chief Financial Officer. With over 20 years of leadership experience in finance, strategy and operations in the life sciences and healthcare sectors, Seth will advance commercial and strategic initiatives, drive revenue and support the Company’s expansion across key global markets. Read the full press release here: https://bit.ly/3XhlYCd

?? Our latest #newsletter is now live! Stay ahead with the latest updates shaping the life sciences industry - from new product launches and strategic collaborations, to appointments and fundraisers. Explore our curated list of articles on emerging industry trends, and check out the upcoming events we'll be attending over the next few weeks. Don't forget to subscribe to stay up-to-date with the latest news! ??